Abstract
IgA nephropathy is the most-common primary glomerulonephritis worldwide, and about 20%–50% of patients develop progressive renal failure. The pathogenesis is still unknown and treatment has not yet been established. Knowledge concerning childhood IgA nephropathy has expanded greatly in the last 10 years, and its importance as the major form of glomerulonephritis and major contributor to end-stage renal disease is also becoming apparent in children. This review focuses on the pathophysiology and treatment of IgA nephropathy in children.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 19 September 2000 / Revised: 18 January 2001 / Accepted: 20 January 2001
Rights and permissions
About this article
Cite this article
Yoshikawa, N., Tanaka, R. & Iijima, K. Pathophysiology and treatment of IgA nephropathy in children. Pediatr Nephrol 16, 446–457 (2001). https://doi.org/10.1007/s004670100582
Issue Date:
DOI: https://doi.org/10.1007/s004670100582